Home » Topics » Regulatory

Regulatory
RSS

NDA filed for Zomig Nasal Spray

March 4, 2002

FDA approves new indication for Plavix in acute coronary syndrome

March 1, 2002

CPMP recommends approval of Glivec for GISTs in Europe

Feb. 27, 2002

Cypress initiates phase II program for milnacipran in fibromyalgia syndrome

Feb. 26, 2002

FDA approves Zometa for bone metastases from solid tumors and multiple myeloma

Feb. 26, 2002

Zomig nasal spray formulation launched in Sweden

Feb. 22, 2002

GlaxoSmithKline launches environmentally friendly reformulation of Ventolin

Feb. 22, 2002

Zevalin therapeutic regimen approved for NHL

Feb. 22, 2002

Casodex 150 mg receives priority review in early-stage prostate cancer

Feb. 21, 2002

Sucampo licenses tacrolimus from Fujisawa for ophthalmic use

Feb. 21, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....